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Abstract: Serine:pyruvate (or alanine:glyoxylate) aminotransferase (SPT or AGT) in the liver
is unique in that its subcellular distribution is entirely peroxisomal in man and herbivores, and largely
mitochondrial in carnivores. In rats, this enzyme is located in both mitochondria and peroxisomes and
only the mitochondrial activity is markedly induced by glucagon. The mechanism of the species-
speciﬁc dual organelle localization is either transcription of the gene from two diﬀerent start sites
or loss of upstream translation initiation ATG codon by mutations. In herbivores, peroxisomal
localization of SPT appears to be indispensable to prevent excessive oxalate production by removing
glyoxylate, an immediate precursor of oxalate, formed from glycolate in this organelle. In carnivores,
its mitochondrial localization appears to be needed to metabolize glyoxylate formed from L-
hydroxyproline in mitochondria. In addition, SPT contributes substantially to gluconeogenesis from
serine in rabbit, human and dog livers, irrespective of its mitochondrial or peroxisomal localization.
Keywords: serine:pyruvate (or alanine:glyoxylate) aminotransferase, peroxisomal and/or
mitochondrial localization, alternative transcription initiation from two start sites, gluconeogenesis
from L-serine, in situ detoxication of glyoxylate, oxalate formation
Introduction
Eukaryotic cells contain cellular organelles such
as a nucleus, mitochondria, lysosomes, and perox-
isomes, each of which is responsible for an important
part of cellular functions. In addition, compartmen-
tation into such organelles of speciﬁc metabolic
processes or enzymes is believed to facilitate regu-
lation of these processes independent of other
processes proceeding elsewhere. In this sense, ala-
nine:glyoxylate (or serine:pyruvate) aminotransfer-
ase (AGT or SPT) in the liver is unique in that its
subcellular distribution is entirely peroxisomal in
man and herbivores and largely mitochondrial in
carnivores.1)–8) In rats and mice this enzyme is
located in both mitochondria and peroxisomes, and
only the mitochondrial activity is markedly induced
by injection of glucagon.4),5),9)–12) Our laboratory in
the Department of Biochemistry, Hamamatsu Uni-
versity School of Medicine, Hamamatsu, Japan has
been interested in this curious liver enzyme, AGT
(or SPT). Our major goal was to elucidate (1) the
physiological role of this enzyme, i.e., whether or
not it is a bifunctional enzyme actually involved in
both the metabolism of L-serine and detoxication of
glyoxylate, and (2) why (for what physiological
need) the subcellular distribution of this enzyme
should be as it is and how (by what molecular
mechanism) it can be species-speciﬁc and food habit-
dependent. Dr. T. Noguchi’s group at Kyushu Dental
College, Japan and Dr. C. J. Danpure’s group at
MRC Laboratory for Molecular Cell Biology,
University College London, also substantially and
creatively contributed to this area of research, but in
this review paper the Hamamatsu approach will be
mainly introduced.
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Serine:pyruvate aminotransferase (SPT,
EC 2.6.1.51) was ﬁrst described in dog liver in
1956.13) At ﬁrst, this enzyme was assumed to be
involved in the biosynthesis of L-serine from 2-
phosphoglycerate, a glycolytic intermediate, via the
non-phosphorylated pathway, the pathway through
D-glycerate and hydroxypyruvate.13) However, a
high activity of liver SPT was subsequently observed
in animals fed a diet low in carbohydrate such as
carnivores,14),15) neonatal suckling rats14),16) and
rabbits fed an 88% casein diet,17) as well as after
administration into rats of glucagon, cAMP or
cortisone14),16),18) and in alloxan diabetes.16),18) These
results together with the eﬀects of diet and hormones
on other enzymes of serine metabolism17),18) sug-
gested that the non-phosphorylated pathway was
associated with gluconeogenesis from L-serine rather
than the serine synthesis. On the other hand, serine
dehydratase (SDH, EC 4.2.1.13), which catalyzes
formation of pyruvate from L-serine, had also been
thought to initiate gluconeogenesis from serine in
fasted adult rat liver, although its substantial
contribution had not been convinced, mainly because
of its high Km (50–70mM) for L-serine. Then, there
was considerable controversy as to the route of
gluconeogenesis from L-serine. At that time, the
relative ﬂow of serine metabolism through SDH and
SPT in rat liver had been studied mainly by the use
of inhibitors of phosphoenolpyruvate carboxykinase
(PEP-CK) such as quinolinate and 3-mercaptopico-
linate, and a contribution of the SPT pathway was
suggested from the observations that these inhibitors
had less eﬀect on gluconeogenesis from serine than
from lactate or alanine.19)–21) Gluconeogenesis from
L-serine through pyruvate (SDH-pathway) as well as
that from L-alanine and lactate involves conversion
of oxaloacetate to phosphoenolpyruvate catalalyzed
by PEP-CK, but that by way of hydroxypyruvate
(SPT pathway) bypasses this PEP-CK-catalyzed
step. However, other studies supported the serine
metabolism primarily via SDH at least in rat liver
under gluconeogenic conditions such as starva-
tion.22)–25) I encountered SPT in 1969 when I was
studying abroad at the Enzyme Institute, University
of Wisconsin. In my study at that time, data
obtained did not support the major role of the SPT
pathway in gluconeogenesis from serine as far as
fasted rat liver was concerned, leaving the actual
physiological role of this enzyme to be studied later.
During this study, however, I found that glucagon-
induced SPT was predominantly localized in mito-
chondria making me very curious to know why
(for what physiological need) glucagon-induced
SPT should be in mitochondria and, assuming the
synthetic site of this enzyme to be cytoplasmic
ribosomes, how the induced SPT molecule was
translocated to this organelle.
SPT was later puriﬁed to homogeneity from
mouse, rat, dog, cat and human livers, and shown
to be a homodimer of approximately 40-kDa sub-
units.1),2),10),26)–30) No notable diﬀerence was observed
between rat liver mitochondrial and peroxisomal
SPTs in their physicochemical and catalytic proper-
ties,29) except that N-terminal amino acid of perox-
isomal SPT was blocked whereas that of mitochon-
drial SPT was methionine.31) However, substrate
speciﬁcity of the enzyme from human, dog and cat
livers was quite diﬀerent from that of rodent SPT.
Despite the name, serine:pyruvate aminotransferase,
rat liver SPT utilized not only L-serine and pyruvate
but also many other neutral L-,-amino acids lacking
branches at the O-C position and their corresponding
,-keto acids as a good amino donor and acceptor,
respectively. An exception was that glycine was a
very poor substrate, although its corresponding ,-
keto acid, glyoxylate, served as a most favorable
amino acceptor.26),29)–31) We noted that the Km of
rat SPT for glyoxylate was as low as approximately
10µM, while the constant for other ,-keto acids was
higher than 0.5mM.30) Mouse liver SPT appeared to
share these properties with rat enzyme.27) On the
other hand, human, dog and cat liver SPT were
shown by Noguchi et al.1),2),27),28) to be speciﬁc for
L-alanine and L-serine as an amino donor and for
pyruvate, hydroxypyruvate and glyoxylate as an
amino acceptor. It was noteworthy that human
enzyme also showed low Km for glyoxylate, suppos-
edly the most physiologically important character-
istic of this enzyme.
Alanine:glyoxylate aminotransferase (AGT,
EC 2.6.1.44) was ﬁrst puriﬁed 800 to 900-fold from
human liver and characterized by Thompson and
Richardson in 1967, and in this ﬁrst paper substrate
speciﬁcity of human AGT was shown to be almost
speciﬁc to L-alanine and L-serine.32) In addition,
supposing the key role of AGT in glyoxylate and
oxalate metabolism, possible involvement of this
enzyme in primary hyperoxaluria or oxalosis was
already discussed.32) Subsequently, the catalytic
properties and response to hormones and dietary
conditions of AGT were shown to be very similar or
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ﬁnally SPT and AGT were concluded to be the same
enzyme. In 1986, Danpure et al. showed that primary
hyperoxaluria type 1, a lethal inborn error of
glyoxylate metabolism characterized by increased
oxalate production, was caused by a deﬁciency of
hepatic peroxisomal AGT (SPT).34),35) Since glyox-
ylate had been known as an immediate precursor of
oxalate, a toxic end-product of metabolism, the vital
importance of its removal by AGT (SPT) was thus
clariﬁed. Hereafter, therefore, this enzyme has been
generally called AGT. However, since we used to call
this enzyme SPT or serine:pyruvate/alanine:glyox-
ylate aminotransferase (SPT/AGT), I will use, in
this review paper, the name SPT instead of more
common name, AGT.
Molecular mechanism underlying the species-
speciﬁc and food habit-dependent dual
organelle distribution of SPT (AGT)
After I moved to Hamamatsu University School
of Medicine in 1974 I started, in collaboration with
my colleagues, to study how glucagon-induced SPT
can be localized in mitochondria in rat liver. First, we
demonstrated, as a prerequisite for further studies,
that the glucagon-induced increase in the activity of
SPT in rat liver occurred mainly in the mitochondrial
matrix of parenchymal cells and this increase was due
to the accumulation of enzyme protein caused by the
rise in the rate of enzyme synthesis.10)
While these studies were in progress, Noguchi
et al. reported that in the liver of normally fed rats
the SPT activity was detected not only in mitochon-
dria but also in peroxisomes, and only the mitochon-
drial activity remarkably increased after administra-
tion of glucagon.9) The physicochemical, kinetic,
and immunological properties of the mitochondrial
and peroxisomal enzymes (SPTm and SPTp, re-
spectively) were indistinguishable from each oth-
er.4),5),9),29) We conﬁrmed these ﬁndings and were
very much interested in the mechanisms underlying
the dual organelle distribution of rat SPT and its
selective accumulation in mitochondria when synthe-
sized in response to glucagon stimuli.12) We then
found in a cell-free protein synthesizing system
that SPT was synthesized, being directed by total
RNA isolated from glucagon-treated rat livers, as a
putative precursor protein which was approximately
2,000Da larger than the subunit of mature en-
zyme.36) The hepatic level of translatable mRNA
coding for the putative precursor was approximately
40 times higher in rats that received a glucagon
administration 3.5h before sacriﬁce than in control
animals.36) As to the intracellular site of biosynthesis
of SPT, immunoprecipitation of [3H]puromycin-
labeled nascent peptides prepared from free and
membrane-bound ribosomes of glucagon-treated
rat liver showed that nascent peptide of SPT was
mainly included in the total nascent peptide on free
ribosomes.37) These results altogether indicated that
SPT destined for mitochondria was synthesized
mainly on extra-mitochondrial free ribosomes as the
larger precursor (preSPT), as in the case of many
other mitochondrial matrix enzymes. Indeed, the
precursor (preSPT) synthesized in vitro was post-
translationally processed to an apparently mature
form by isolated rat liver mitochondria, and the
processed product was localized in the matrix of
mitochondria.37)
We then cloned, being instructed by Prof.
Shigetada Nakanishi of Kyoto University, cDNA for
SPT from rat livers.38) Nineteen cDNA clones were
isolated by screening of a cDNA expression bank of
rat liver with an antibody against the enzyme, and
one of the clones named pRspt10 contained the entire
coding region for the mature enzyme and expressed
in bacteria a speciﬁc 43-kDa protein having the
immunoprecipitable activity of SPT. In RNA blot
analysis performed with a [32P]-labeled cDNA frag-
ment as a probe, two types of SPT-mRNA with
diﬀerent sizes were detected. The larger mRNA
was composed of approximately 1900 nucleotides
and induced by glucagon, while the smaller one of
approximately 1700 nucleotides was not aﬀected by
the hormone.38) In good agreement with the two
types of SPT-mRNA, two immunoprecipitable prod-
ucts of diﬀerent size (45kDa and 43kDa) were
detected in the in vitro translation, and when RNA
from glucagon-treated rats were used to direct
protein synthesis the formation of the 45-kDa
product markedly increased.38),39) These results
indicated that mitochondrial SPT (SPTm) was
synthesized through the 1900-nucleotide mRNA
(SPTm-mRNA) and the 45-kDa precursor
(preSPTm) and that glucagon caused the induction
of the enzyme by increasing the level of the 1900-
nucleotide mRNA. The remaining 1700-nucleotide
mRNA and 43-kDa translation product were pre-
sumed to be connected with the synthesis of
peroxisomal SPT (SPTp) (cf. Fig. 1-B).
Although pRspt10 covered the entire coding
region of the mature enzyme, it lacked the nucleotide
sequence encoding the N-terminal extension peptide
essential for the proper translocation of the amino-
A. ICHIYAMA [Vol. 87, 276Fig. 1. Transcription of the rat SPT gene from two diﬀerent initiation sites (A) and schematic representation of the biosynthesis of
SPTm and SPTp from a single rat SPT gene (B). In (A), the two transcription initiation sites detected on primer extension and S1
nuclease mapping41) are indicated by arrows and arrowheads, respectively. A (adenine) of ATG corresponding to the ﬁrst AUG
translation initiator codon of SPTm-mRNA is numbered 1. Methionine codons (ATG) are underlined. The amino acid sequence is
represented by one-letter abbreviations, and basic amino acid residues in the mitochondria-targeting N-terminal extension sequence of
the 45kDa-precursor of SPTm (preSPTm) are denoted by D. This region has been predicted to fold as an amphiphilic ,-helix.
Figure 1-A is reprinted from Funai et al.44) In (B), the two transcription start sites and translation initiation ATG triplets in exon 1 of
the rat SPT gene are indicated by hooked arrows and (M), respectively. PreSPTm also contains C-terminal peroxisomal targeting
sequence (PTS), but N-terminal mitochondrial targeting sequence (MTS) was shown to be functionally dominant over the C-terminal
PTS.46)
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cloned cDNAs encoding an entire sequence of the 45-
kDa precursor were then isolated by screening an
Okayama–Berg library by using a cloned cDNA
fragment as a probe.40) Sequence analysis of one of
the cloned cDNAs isolated, pRspt321, enabled us to
deduce the primary structure of the 45-kDa precursor
and the mature form of the enzyme. The precursor
was revealed to be a protein of 414 amino acids
containing an extra-peptide (pre-sequence) of 22
amino acids at the NH2-terminus of the mature
enzyme of 392 amino acids.40) Upon RNA blot
analysis and S1 nuclease protection assay no dif-
ferences were detected between the two mRNAs
other than that about 100 nucleotides of the 5′-
terminal sequence of the 1900-nucleotide mRNA
(SPTm-mRNA) were lacking in the 1700-nucleotide
mRNA (SPTp-mRNA), and the length of the
poly(A) tail was diﬀerent.41) Southern blot analysis
of genomic DNA extracted from rat liver strongly
suggested that the SPT gene was single, that was,
both the SPTm- and SPTp-mRNAs were transcribed
from a single gene.41) Indeed, we have isolated
genomic clones harboring the entire rat SPT gene,41)
characterized them,42) and later determined the
location of the single rat SPT gene to be in the
q34–q36 region of chromosome 9 by ﬂuorescence
in situ hybridization.43) Primer extension and S1
nuclease mapping analysis, using a DNA fragment of
a genomic clone, revealed that the SPTm- and SPTp-
mRNAs were transcribed from diﬀerent initiation
sites, about 65 nucleotides apart, in the same exon,
exon 1 (Fig. 1-A).41) Ribonuclease protection assay
performed with an RNA hybridization probe corre-
sponding to the 5′-terminal portion of SPTm-mRNA
also gave the same results. These results altogether
indicated that diﬀerent organelle distribution of
SPTm and SPTp, the products of the same SPT
gene, arose from transcription from diﬀerent initia-
tion sites. Transcription from the upstream start
site generates the 1900-nucleotide mRNA for a 45-
kDa precursor for SPTm containing a cleavable N-
terminal mitochondrial targeting signal of 22 amino
acids. The precursor is translocated into mitochon-
dria and converted to the mature size (43kDa) by
processing. On the other hand, transcription from the
downstream start site (D66 relative to the upstream
start site) generates the 1700-nucleotide mRNA that
encodes a product of mature size. The product is then
imported into peroxisomes by an intramolecular
peroxisomal targeting signal type 1 (PTS1) at the
C-terminal region (Fig. 1-B).45)–47) Indeed, when a
truncated cDNA was constructed to encode the 43-
kDa translation product and expressed in cultured
monkey kidney COS-1 cells SPT immunoreactivity
was exclusively peroxisomal. When the cDNA
encoding the 45kDa-product was expressed, on the
other hand, SPT immunoreactivity was largely
localized in mitochondria.48)
Studies on the eﬀect of glucagon on SPT gene
expression in primary cultured rat hepatocytes
showed that activation by glucagon of transcription
from the upstream initiation site was responsible for
the hormone-induced increase in the cellular level of
SPTm-mRNA.49) This eﬀect of glucagon was shown
to be mediated by the cAMP/protein kinase A
(PKA) system,49) but in this gene, a CRE (cAMP-
responsive element)-like sequence was found only
at !673/!666 (relative to upstream transcription
start site),42) and there was no evidence that this
CRE-like sequence was involved in the transcription
activation. Instead, Sp1 site at !113/!106 and AP-2
site at !1/D9 were shown to be essential for the
upstream promoter activity of the rat SPT gene.50)
Expression of AP-2 caused a marked increase in the
basal promoter activity, and both the basal and
PKA-induced activities were elevated by over-ex-
pression of Sp1, its eﬀect on the PKA-induced
activity being more pronounced with co-expression
of CBP (CREB-binding protein) and repressed by
E1A oncoprotein.50) These results suggested that AP-
2 and Sp1 regulated basal activity of the upstream
promoter, and Sp1 was also involved in the
PKA-mediated expression of the rat SPT gene in
concert with the transcriptional co-activator CBP.
The downstream promoter activity appeared to be
constitutively regulated by C/EBP, and C/EBPO
which bound around the downstream transcription
start site (D66 relative to the upstream start site)
and still unidentiﬁed protein factors bound to a short
inverted repeat located 20–30bp upstream of the
downstream start site.51)
While we were devoted to studying the tran-
scriptional regulation responsible for the hormone-
induced and constitutive synthesis of rat mitochon-
drial and peroxisomal SPT, Lumb, Purdue and
Danpure52) showed that transcription of the AGT
(SPT) gene in cats occurs almost entirely from a
single site corresponding to the upstream start site
in the rat SPT gene, consistent with the largely
mitochondrial localization of SPT. In rabbits and
humans, similar start sites were also found, but
the upstream AUG codon for translation of the N-
terminal mitochondrial targeting sequence had been
A. ICHIYAMA [Vol. 87, 278mutated to ACA and AUA, respectively.53),54) In
this case, the ﬁrst methionine codon encountered in
translation should be the downstream AUG at D67
(relative to A of upstream AUG), consistent with
the entirely peroxisomal localization of the enzyme
in these animal species (Fig. 2). Marmoset, a New
World monkey, has AGT (SPT) in both mitochon-
dria and peroxisomes in the liver, and in this animal
species two SPT-mRNAs are formed by transcription
from upstream and downstream start sites, as in the
case of the rat.54)
It was thus revealed that the major determinant
of the SPT organelle destination was the AUG codon
ﬁrst encountered in translation, as we had ﬁrst
proposed to explain the organelle distribution of rat
liver SPT in the presence and absence of glucagon
stimuli.41) When the longer mRNA (SPTm-mRNA)
was translated from the upstream AUG codon at D1
position preSPTm containing a mitochondria-target-
ing N-terminal signal sequence was formed. Mutation
of the upstream AUG codon and generation of the
shorter mRNA (SPTp-mRNA) were used as a means
to allow usage of the downstream AUG codon at D67
position as an initiation codon for synthesis of
peroxisomal SPT (Fig. 2). It appears that the tran-
scription from the downstream start site to produce
SPTp-mRNA has been used to distribute SPT to
peroxisomes in addition to mitochondria.
Physiology of the species-speciﬁc and food habit-
dependent dual organelle distribution of SPT
It has been generally accepted from the known
over-production of oxalate in primary hyperoxaluria
type 1, an inborn error of glyoxylate metabolism
caused by a functional deﬁciency of peroxisomal
SPT,34),35) that one of the major physiological roles
of SPT in this organelle was removal of glyoxylate
by catalysis of its conversion to glycine, at least in
humans. SPT had also been presumed to participate
in gluconeogenesis from serine but supporting evi-
dence was still insuﬃcient. In this connection, it was
noteworthy that the liver SDH activity was known
to be inversely related to body size in mammals,57)
suggesting a possibility that the contribution of SDH
to the serine metabolism, if any, sharply decreased
with increasing body size of animals. Therefore, we
studied L-serine metabolism in rat (24-h starved and
glucagon-treated), rabbit, human and dog livers,
focusing on the relative contribution of SPT.58),59)
The ﬂux of serine metabolism in the liver by way of
the three pathways, one initiated by SDH, another
by SPT, and the other the pathway through glycine
Fig. 2. Initiation of transcription and translation. The SPT-mRNA of diﬀerent animal species is schematically shown. A of the ﬁrst AUG
initiator codon of SPTm-mRNA is numbered D1. Methionine codons (AUG) are double underlined, and nucleotides at positions !3
and D4 (numbers are relative to A of AUG) are underlined. Kozak55) has shown that nucleotide at positions !3 and that at D4 should
be purines (A or G) and G, respectively, for eﬃcient translation initiation from the AUG codon. In rat SPTm-mRNA, there is another
AUG triplet at position D10, but this AUG is omitted from the ﬁgure, because nucleotide at position !3 and that at D4 of this AUG
are C and T, not A or G and G, respectively (cf. Fig. 1), and there is no evidence that it is used for initiation of translation. The
ﬁrst AUG codon of rat SPTm-mRNA is in a suboptimal context in that nucleotide at position !3 is G but that at D4 is U. In the
translation of the longer mRNA, therefore, some ribosomal subunits bypass the ﬁrst AUG codon and reach the third AUG codon at
D67, which is in a favorable context, and initiate translation to produce the 43-kDa product.44) Mar, marmoset; Rab, rabbit; Hum,
human. Reprinted from Ichiyama et al.56)
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SDH and SPT to gluconeogenesis from L-serine was
estimated in vivo and in perfused liver using L-
[3-3H, 14C]serine as substrate. The principle of the
in vivo and perfusion experiments is shown in Fig. 3.
The carbon derived from the 3-position of L-serine is
thought to be retained throughout the gluconeogenic
reactions in either pathway. On the other hand, the
hydrogen at the 3 position is expected to be largely
removed in the gluconeogenesis via pyruvate (SDH-
pathway), whereas it is retained most in gluconeo-
genesis via hydroxypyruvate (SPT-pathway). The
results of the in vitro and in vivo experiments are
summarized in Table 1. In rat liver, ﬂux through
SDH was predominant, and the contribution of SPT
was about 1/10–1/7 of that through SDH even after
Fig. 3. Presumed metabolic fates of carbon and hydrogen at the 3-position of L-serine in gluconeogenesis via pyruvate (A) and
hydroxypyruvate (B). ￿ and *: carbon and hydrogen originating from those at the 3-position of L-serine, respectively. (*): 3H that is
expected to be lost on the fumarase-catalyzed shuttling between malate and fumarate. In the gluconeogenic pathway via pyruvate
(A), no intermediates after oxaloacetate in the cytosol are labeled with *, emphasizing the removal of this hydrogen in mitochondria.
(￿): 14C labeling attributable to randomization at the succinate dehydrogenase step. LDH: lactate dehydrogenase, OAA: oxaloacetate,
PC: pyruvate carboxylase, mGOT and cGOT: mitochondrial and cytosolic aspartate aminotransferase, respectively, mMDH and
cMDH: mitochondrial and cytosolic malate dehydrogenase, respectively, PEP: phosphoenolpyruvate, PEPCK: phosphoenolpyruvate
carboxykinase, SucDH: succinate dehydrogenase, 2-PGA: 2-phosphoglycerate, DGDH/GR: D-glycerate dehydrogenase/glyoxylate
reductase, DGK: D-glycerate kinase, Mit: mitochondria, Cyt: cytosol. Reprinted from Xue et al.58)
A. ICHIYAMA [Vol. 87, 280glucagon injection. In rabbit, man and dog, on the
other hand, SPT was the major enzyme of hepatic
serine metabolism, and in rabbit the contribution
of SPT to gluconeogenesis from serine was estimated
to be as much as about 90%. These results were in
good agreement with the observations of Beliveau
and Freedland60) that serine is mainly metabolized
via transamination in hepatocytes isolated from cats,
and also compatible with the results of Rowsell
et al.61) that in rabbit and dog livers SPT activity is
more than six times higher, and SDH activity is much
lower than the respective activities in rat liver. It
was noteworthy that SPT was involved in L-serine
metabolism, no matter whether the enzyme is largely
located in mitochondria (dog liver) or entirely in
peroxisomes (rabbit and human livers).
Therefore, the species-speciﬁc and food habit-
dependent organelle distribution of SPT might be
required for proper metabolism of glyoxylate at the
subcellular site of its formation. In herbivores, a
major source of glyoxylate has been believed to be
oxidation of glycolate by glycolate oxidase in liver
peroxisomes. Glycolate is an intermediate of photo-
respiration and is thus much higher in content in
plants than in animal tissues,62) although its con-
tent in vegetables and fruits is not very high, around
2t o3m g /100g of wet weight. However, because the
energy available from a given wet weight of plants is
much lower than that from meat, herbivores should
be heavy eaters to supply enough energy to maintain
body functions, growth, and so on. A portion of the
ingested glycolate is excreted unchanged in the urine,
but a signiﬁcant portion is oxidized to glyoxylate
by glycolate oxidase in peroxisomes. Therefore, the
peroxisomal localization of SPT may be indispensa-
ble for herbivores to convert glyoxylate thus formed
into glycine in situ, preventing undesirable over-
ﬂow of it into oxalate, a dangerous endproduct of
metabolism. Glyoxylate is also formed in liver and
kidney mitochondria from 4-hydroxy-2-ketogluta-
rate, an intermediate of L-hydroxyproline metabo-
lism (Fig. 4).63),64) Mitochondrial production of
glyoxylate from hydroxyproline is assumed to be
signiﬁcant in carnivores, because the hydroxyproline
Table 1. Flux of serine metabolism in the liver
Rat
Rabbit Human Dog
Starved
Glucagon-
treated
nmol/60min/40mg liver equiv. (%)
In vitro experiment
SDH pathway 144 220 90 90 90
(%) (98) (89)
SPT pathway 901 95 0 3 8 2 6
(%) (8) (96) (88) (57)
Via glycine 2.6 6 2 5 20
(%) (2) (3) (4) (12) (43)
Contribution to gluconeogenesis in vivo
SDH (%) 997 988 910 ——
SPT (%) 93 912 990 ——
Data from Xue et al.58),59)
Fig. 4. Catabolic pathway of L-hydroxyproline in mitochondria. AspAT: aspartate aminotransferase, DH: dehydrogenase, Hyp:
hydroxyproline, OAA: oxaloacetate, 4-OH-Glu: 4-hydroxy-L-glutamate.
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accounts for about 30% of total animal protein. We
thus examined whether mitochondrial SPT plays a
role in removing hydroxyproline-derived glyoxylate
from oxidation to oxalate using rats with or without
glucagon induction of liver mitochondrial SPT.66)
When a large dose of L-hydroxyproline was admin-
istered orally to 48h-fasted control rats urinary
excretion of oxalate and glycolate was signiﬁcantly
increased (oxalate, 5.6-fold; glycolate, 2.5-fold), and
this increase was eﬀectively prevented by prior
induction of liver mitochondrial SPT by glucagon
(Fig. 5). Administration of glycolate also caused a
marked increase (about 8-fold) in oxalate excretion
into urine, but the glycolate-derived oxalate was not
signiﬁcantly aﬀected by the glucagon induction of
mitochondrial SPT, as expected (Fig. 6). These
results suggested that mitochondrial presence of
SPT in carnivores is important for the in situ
metabolism of glyoxylate formed from L-hydroxypro-
line in mitochondria. The necessity of peroxisomal
localization of SPT in humans for eﬃcient removal
of glyoxylate in this organelle was demonstrated by
Danpure et al.67) by showing that SPT misrouted to
mitochondria in a group of patients with primary
hyperoxaluria type 1 cannot fulﬁll its metabolic role
of detoxicating glyoxylate properly.
As to the formation of oxalate from glyoxylate,
it is important that glyoxylate in aqueous solutions
exists largely in a hydrated form and is structurally
similar to an ,-hydroxy acid. The oxidation of
glyoxylate to oxalate is catalyzed in vitro by
Fig. 5. Urinary excretion of oxalate and glycolate after administration of L-hydroxyproline. Where indicated, 630mg of L-
hydroxyproline in 2ml water was administered to glucagon-treated rats and control fasted rats via a stomach tube, followed by
collection of 24-h urine. Then the SPT activity in liver homogenate and oxalate in the 24h-urine were determined. L-Hyp: L-
hydroxyproline. Data from Takayama et al.66)
Fig. 6. Urinary excretion of oxalate and glycolate after administration of glycolate. Where indicated, 100mg of Na-glycolate in 1ml
water was administered to glucagon-treated rats and control fasted rats via a stomach tube. Data from Takayama et al.66)
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(LDH), a short-chain ,-hydroxy acid oxidase and
dehydrogenase, respectively, between which LDH
may be mainly responsible for the oxalate production
in vivo.68) As already stated by Richardson and
Tolbert for glycolate oxidase,69) the oxalate forma-
tion from glyoxylate by LDH or glycolate oxidase
may be an unnecessary occurrence, because for both
these enzymes their presence is needed for other
purposes; for LDH dehydrogenation of L-lactate
to pyruvate with generation of NADH and for
glycolate oxidase oxidation of glycolate to glyoxylate.
We agree with Richardson and Tolbert69) that the
oxalate production from glyoxylate may occur as
a consequence of an evolutionary limit in the
development of an enzymatic site of LDH which
would react with L-lactate but would not attack
the hydrated glyoxylate molecule of nearly similar
structure.
Oxalate is thought to be a useless end-product
of metabolism in mammals and is excreted into
urine largely as a water-insoluble calcium salt. Thus
crystallization of calcium oxalate can cause pathol-
ogy by obstructing tubular lumens, disrupting
intercellular and possibly intracellular interactions,
or simply killing cells within which or next to which
crystallization occurs. What happens when the
unnecessary production of oxalate is not properly
curtailed may be represented by the symptoms and
prognosis of primary hyperoxaluria type 1. This
hereditary disease caused by a functional deﬁciency
of peroxisomal SPT is characterized by progressive
calcium oxalate urolithiasis, nephrocalcinosis and
systemic oxalosis due to increased oxalate produc-
tion, and the patients usually die before the third
decade of age, unless enzyme replacement therapy
such as hepatorenal transplantation was properly
performed.35),70) It is attractive to speculate that the
removal of glyoxylate, an immediate precursor of
oxalate, at the subcellular site of its production
would be a practical way to reduce oxalate formation,
and those animal species that succeeded in equipping
the proper subcellular site with SPT, an enzyme with
low Km for glyoxylate, survived evolutionary.
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